Table 2.

Univariable Cox regression for PFS and DSS in patients with aGCA.

Characteristics	PFS				DSS
	n	HR	95% CI	P-value	HR	95% CI	P-value
Sex
Male	11	1			1
Female	9	1.19	(0.36–3.93)	0.776	1.47	(0.37–5.78)	0.581
Age at diagnosis	30	1.003	(0.95–1.06)	0.925	1.01	(0.94–1.08)	0.856
Lymph node involvement
No	16	1			1
Yes	9	1.12	(0.96–9.77)	0.144	3.86	(0.96–15.60)	0.097
Unknown	5	0.71	(0.47–8.64)		1.11	(0.11–10.93)
M status
M0	17	1			1
M1b	9	2.72	(0.82–9.00)	0.102	4.21	(0.81–22.00)	0.087
WHO grade
1	14	1			1
2	6	7.28	(0.81–65.50)	0.076	3.81	(0.35–42.12)	0.275
3	10	18.68	(2.24–155.59)	0.007	10.21	(1.23–85.08)	0.032

Bold indicates statistical significance. aGCA, appendiceal goblet cell adenocarcinoma; PFS, progression-free survival; DSS, disease-specific survival.